Table of contents
Volume 99, Issue 5
Published online 26 August 2008 (681-840)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor
Editorial
Norman Bleehen
Davina Honess
Br J Cancer 99: 681-682; doi:10.1038/sj.bjc.6604542
Minireviews
Role of LKB1 in lung cancer development
L Makowski and D N Hayes
Br J Cancer 99: 683-688; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604515
Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
L Nolan, P W M Johnson, A Ganesan, G Packham and S J Crabb
Br J Cancer 99: 689-694; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604557
Clinical Studies
Waiting times for systemic cancer therapy in the United Kingdom in 2006
M V Williams, K J Drinkwater, A Jones, B O'Sullivan and D Tait
Br J Cancer 99: 695-703; doi:10.1038/sj.bjc.6604529
Automated telephone follow-up after breast cancer: an acceptability and feasibility pilot study
D A Montgomery, K Krupa, C Wilson and T G Cooke
Br J Cancer 99: 704-710; doi:10.1038/sj.bjc.6604567
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer
B Sherrill, M M Amonkar, S Stein, M Walker, C Geyer and D Cameron
Br J Cancer 99: 711-715; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604501
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, D Santini, V Catalano, E Canestrari, P Maltese, R Bisonni, L Fornaro, G Baldi, G Masi, A Falcone, G Tonini, P Giordani, P Alessandroni, L Giustini, B Vincenzi and M Magnani
Br J Cancer 99: 716-721; advance online publication, August 12, 2008; doi:10.1038/sj.bjc.6604555
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer
P M Hoff, S Kopetz, M B Thomas, A Langleben, D Rinaldi, L Anthony, R A Wolff, Y Lassere and J L Abbruzzese
Br J Cancer 99: 722-726; advance online publication, August 12, 2008; doi:10.1038/sj.bjc.6604541
Poorer outcome in stromal HIF-2
- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis
A H G Cleven, B G Wouters, B Schutte, A J G Spiertz, M van Engeland and A P de Bruïne
Br J Cancer 99: 727-733; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604547
Phase II trial of imatinib mesylate in patients with metastatic melanoma
K B Kim, O Eton, D W Davis, M L Frazier, D J McConkey, A H Diwan, N E Papadopoulos, A Y Bedikian, L H Camacho, M I Ross, J N Cormier, J E Gershenwald, J E Lee, P F Mansfield, L A Billings, C S Ng, C Charnsangavej, M Bar-Eli, M M Johnson, A J Murgo and V G Prieto
Br J Cancer 99: 734-740; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604482
Translational Therapeutics
Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases
S H Kim, F Castro, D Gonzalez, P C Maciag, Y Paterson and C Gravekamp
Br J Cancer 99: 741-749; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604526
Molecular pathways involved in the synergistic interaction of the PKC
inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells
C Tekle, E Giovannetti, J Sigmond, J R Graff, K Smid and G J Peters
Br J Cancer 99: 750-759; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604566
Molecular Diagnostics
Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
C W Michalski, M Erkan, D Sauliunaite, T Giese, R Stratmann, C Sartori, N A Giese, H Friess and J Kleeff
Br J Cancer 99: 760-767; doi:10.1038/sj.bjc.6604528
Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
E Bignotti, A Ravaggi, R A Tassi, S Calza, E Rossi, M Falchetti, C Romani, E Bandiera, F E Odicino, S Pecorelli and A D Santin
Br J Cancer 99: 768-773; advance online publication, August 5, 2008; doi:10.1038/sj.bjc.6604546
Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease
M W Helms, D Kemming, H Pospisil, U Vogt, H Buerger, E Korsching, C Liedtke, C M Schlotter, A Wang, S Y Chan and B H Brandt
Br J Cancer 99: 774-780; advance online publication, August 12, 2008; doi:10.1038/sj.bjc.6604556
Induction of sodium iodide symporter gene and molecular characterisation of HNF3/FoxA2, TTF-1 and C/EBP in thyroid carcinoma cells
T Akagi, Q T Luong, D Gui, J Said, J Selektar, A Yung, C M Bunce, G D Braunstein and H P Koeffler
Br J Cancer 99: 781-788; advance online publication, August 5, 2008; doi:10.1038/sj.bjc.6604544
Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
T G Ntouroupi, S Q Ashraf, S B McGregor, B W Turney, A Seppo, Y Kim, X Wang, M W Kilpatrick, P Tsipouras, T Tafas and W F Bodmer
Br J Cancer 99: 789-795; advance online publication, August 5, 2008; doi:10.1038/sj.bjc.6604545
Epidemiology
Association of early life factors and brain tumour risk in a cohort study
M M Cantwell, M R Forman, R J Middleton and L J Murray
Br J Cancer 99: 796-799; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604615
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
S Franceschi, L Dal Maso, M Rickenbach, J Polesel, B Hirschel, M Cavassini, A Bordoni, L Elzi, S Ess, G Jundt, N Mueller and G M Clifford and the Swiss HIV Cohort Study
Br J Cancer 99: 800-804; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604520
A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland
S A McDonald, S J Hutchinson, S M Bird, C Robertson, P R Mills, J F Dillon and D J Goldberg
Br J Cancer 99: 805-810; doi:10.1038/sj.bjc.6604563
Body size and the risk of biliary tract cancer: a population-based study in China
A W Hsing, L C Sakoda, A Rashid, J Chen, M C Shen, T Q Han, B S Wang and Y T Gao
Br J Cancer 99: 811-815; doi:10.1038/sj.bjc.6604616
Dietary intake of selected B vitamins in relation to risk of major cancers in women
G C Kabat, A B Miller, M Jain and T E Rohan
Br J Cancer 99: 816-821; advance online publication, July 29, 2008; doi:10.1038/sj.bjc.6604540
Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis
G Frost, A-H Harding, A Darnton, D McElvenny and D Morgan
Br J Cancer 99: 822-829; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604564
Survival from cancer in teenagers and young adults in England, 1979–2003
J M Birch, D Pang, R D Alston, S Rowan, M Geraci, A Moran and T O B Eden
Br J Cancer 99: 830-835; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604460
Letters to the Editor
Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver
M-O Riener, M Bawohl, P-A Clavien and W Jochum
Br J Cancer 99: 836; advance online publication, July 15, 2008; doi:10.1038/sj.bjc.6604498
In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
R D Blumenthal, H J Hansen and D M Goldenberg
Br J Cancer 99: 837-838; advance online publication, August 12, 2008; doi:10.1038/sj.bjc.6604548
Reply: In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
S Q Ashraf, P J Conaghan, J L Wilding and W F Bodmer
Br J Cancer 99: 839-840; advance online publication, August 12, 2008; doi:10.1038/sj.bjc.6604549
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.